Fig. 2From: Efficient tumor synergistic chemoimmunotherapy by self-augmented ROS-responsive immunomodulatory polymeric nanodrugCellular uptake and ROS assay. A–C Cellular uptake of nile red (NR) labelled PTX@PoxMTP NPs in MDA-MB-231 and 4T1 cells using CLSM and flow cytometry. (D and E) Flow cytometry and analysis of ROS production in tumor cells after PTX@PoxMTP NPs treatment. *P < 0.05, **P < 0.001Back to article page